簡介:4-羥基他莫昔芬,4-Hydroxytamoxifen是一種選擇性的雌激素受體調(diào)節(jié)劑 (SERM)。
4-羥基他莫昔芬物理化學(xué)性質(zhì):
密度 |
1.1±0.1 g/cm3 |
沸點(diǎn) |
514.4±50.0 °C at 760 mmHg |
熔點(diǎn) |
105-107oC |
分子式 |
C26H29NO2 |
分子量 |
387.514 |
閃點(diǎn) |
264.9±30.1 °C |
精確質(zhì)量 |
387.219818 |
PSA |
32.7 |
LogP |
7.34 |
外觀性狀 |
固體 |
蒸汽壓 |
0.0±1.4 mmHg at 25°C |
折射率 |
1.597 |
儲存條件 |
2-8°C |
穩(wěn)定性 |
Stable. Store cool. Incompatible with strong oxidizing agents. |
水溶解性 |
95% ethanol: 20 mg/mL |
4-羥基他莫昔芬詳細(xì)介紹:
中文名稱: |
4-羥基他莫昔芬 |
中文別名: |
4-羥基他莫昔芬;(Z)-4-(1-[4-(二甲基氨基乙氧基)苯基]-2-苯基-1-丁烯)苯酚;4-羥基三苯氧胺;(R)-4-[1-羥基-2-[[4-(4-羥基苯基)丁基]氨基]乙基]-1,2-苯二醇;(z)-4-羥基它莫西芬;4-羥基三苯氧胺(Z異構(gòu)體);4-羥基三苯氧胺(Z異構(gòu)體和E異構(gòu)體);4-羥基他莫西芬 |
英文名稱: |
4-Hydroxytamoxifen |
英文別名: |
4-Hydroxytamoxifen;(Z)-4-(1-[4-(Dimethylaminoethoxy)phenyl]-2-phenyl-1-butenyl)phenol;(Z)-4-Hydroxy Tamoxifen;trans-4-Hydroxytamoxifen;(Z)-4-OHT;(Z)-4-Hydroxytamoxifen;Afimoxifene;Hydroxytamoxifen;4-Monohydroxytamoxifen;Tamogel;Ici 79280;(E/Z)-4-Hydroxytamoxifen;4-OH-TAM;(Z)-4-(1-(4-(2-(Dimethylamino)ethoxy)phenyl)-2-phenylbut-1-en-1-yl)phenol;Z-4-hydroxytamoxifen;ICI 79,280;TAMOXIFEN, 4-HYDROXY-, (Z)-;(E/Z)-4-Hydroxy Tamoxifen;MLS000069742;C26H29NO2;95K54647BZ;SMR000058939;4-(1-(4-(2-(Dimethylamino)ethoxy)phenyl |
CAS號: |
68047-06-3 |
分子式: |
C26H29NO2 |
分子量: |
387.51 |
詳細(xì)描述 |
博飛美科商城提供的[Sigma-Aldrich]4-Hydroxytamoxifen為博飛美科出品的其它生化試劑,產(chǎn)品穩(wěn)定,定制速度快,極大地方便了廣大科研客戶的使用需求。產(chǎn)品包裝為25MG,安全運(yùn)輸。 屬性: 質(zhì)量水平:300 測定:≥98% (HPLC) 形式:powder 儲存條件: desiccated protect from light 溶解性: methanol: 10 mg/mL ethanol: 20 mg/mL (with heating) 抗生素抗菌譜:neoplastics 作用機(jī)制:enzyme | inhibits 儲存溫度:2-8°C SMILES string:CC\C(c1ccccc1)=C(/c2ccc(O)cc2)c3ccc(OCCN(C)C)cc3 包裝: 5, 25 mg in glass bottle 生化/生理作用: 4-羥基他莫昔芬是他莫昔芬(tamoxifen)的活性代謝物,結(jié)合雌激素受體(ER)和雌激素相關(guān)受體(ERR),具有雌激素和抗雌激素作用。它是細(xì)胞滲透性的選擇性雌激素受體調(diào)節(jié)劑(SERM)。在配體依賴內(nèi)含肽工程Cas9變體中,4-羥基他莫昔芬用于調(diào)控Cas9功能,降低CRISPR介導(dǎo)的基因編輯的脫靶效應(yīng)。 查詢關(guān)鍵詞:“68047-06-3,4-羥基他莫昔芬,4-Hydroxytamoxifen,Sigma-Aldrich,上?,F(xiàn)貨,以Sigma官網(wǎng)為準(zhǔn)”。 |
4-羥基他莫昔芬參考文獻(xiàn):
[1]. Jordan VC, et al. A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity. J Endocrinol. 1977 Nov;75(2):305-16.
[2]. Davis KM, et al. Small molecule-triggered Cas9 protein with improved genome-editing specificity. Nat Chem Biol. 2015 May;11(5):316-8.
[3]. Kuo YM, et al. 4-Hydroxytamoxifen attenuates methamphetamine-induced nigrostriatal dopaminergic toxicity in intact and gonadetomized mice. J Neurochem. 2003 Dec;87(6):1436-43.